title: An uncommon insertion mutation in exon 19 of EGFR showed stable disease after TKI treatment.
authors.affiliation: *Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong; and †Department of Clinical Oncology, Tuen Mun Hospital, Hong Kong.
authors.forename: Anthony W H
authors.initials: AW
authors.lastname: Chan
authors.forename: Joanna H M
authors.initials: JH
authors.lastname: Tong
authors.forename: Sing-Hung
authors.initials: SH
authors.lastname: Lo
authors.forename: Ka Fai
authors.initials: KF
authors.lastname: To
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D066246:ErbB Receptors / Q000235:genetics*; D000069347:Erlotinib Hydrochloride; D005091:Exons / Q000235:genetics*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008875:Middle Aged; D016254:Mutagenesis, Insertional; D009154:Mutation / Q000235:genetics*; D011379:Prognosis; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*
chemical_list: D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; C512478:EGFR protein, human; D066246:ErbB Receptors